Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapeutic microRNA-based strategies in cardiovascular disease discriminate sex and age difference.

Literature DB >> 27739075

Therapeutic microRNA-based strategies in cardiovascular disease discriminate sex and age difference.

Changhai Tian¹, Irving H Zucker².

Abstract

Entities: Disease

Mesh：

Substances：
MicroRNAs

Year: 2016 PMID： 27739075 PMCID： PMC5063941 DOI： 10.1113/JP272892

Source DB: PubMed Journal: J Physiol ISSN： 0022-3751 Impact factor: 5.182

Keyword Cloud
References

× No keyword cloud information.

14 in total

1. MicroRNA-34a: a new piece in the cardiac aging puzzle.

Authors: Ying Ann Chiao
Journal: Circ Cardiovasc Genet Date: 2013-08

2. Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.

Authors: Bianca C Bernardo; Jenny Y Y Ooi; Aya Matsumoto; Yow Keat Tham; Saloni Singla; Helen Kiriazis; Natalie L Patterson; Junichi Sadoshima; Susanna Obad; Ruby C Y Lin; Julie R McMullen
Journal: J Physiol Date: 2016-07-20 Impact factor: 5.182

3. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture.

Authors: E Barrett-Connor
Journal: Circulation Date: 1997-01-07 Impact factor: 29.690

4. MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors.

Authors: Jayavarshni Ganesan; Deepak Ramanujam; Yassine Sassi; Andrea Ahles; Claudia Jentzsch; Stanislas Werfel; Simon Leierseder; Xavier Loyer; Mauro Giacca; Lorena Zentilin; Thomas Thum; Bernhard Laggerbauer; Stefan Engelhardt
Journal: Circulation Date: 2013-04-26 Impact factor: 29.690

5. Gender differences in post-infarction hypertrophy in end-stage failing hearts.

Authors: Deborah L Crabbe; Konstantina Dipla; Srivani Ambati; Andreas Zafeiridis; John P Gaughan; Steven R Houser; Kenneth B Margulies
Journal: J Am Coll Cardiol Date: 2003-01-15 Impact factor: 24.094

6. MicroRNA-34a regulates cardiac ageing and function.

Authors: Reinier A Boon; Kazuma Iekushi; Stefanie Lechner; Timon Seeger; Ariane Fischer; Susanne Heydt; David Kaluza; Karine Tréguer; Guillaume Carmona; Angelika Bonauer; Anton J G Horrevoets; Nathalie Didier; Zenawit Girmatsion; Peter Biliczki; Joachim R Ehrlich; Hugo A Katus; Oliver J Müller; Michael Potente; Andreas M Zeiher; Heiko Hermeking; Stefanie Dimmeler
Journal: Nature Date: 2013-02-20 Impact factor: 49.962

Therapeutic microRNA-based strategies in cardiovascular disease discriminate sex and age difference.

1. MicroRNA-34a: a new piece in the cardiac aging puzzle.

2. Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.

3. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture.

4. MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors.

5. Gender differences in post-infarction hypertrophy in end-stage failing hearts.

6. MicroRNA-34a regulates cardiac ageing and function.

7. Influence of sex differences on microRNA gene regulation in disease.

8. Associations of circulating plasma microRNAs with age, body mass index and sex in a population-based study.

9. Estrogen Regulation of MicroRNA Expression.

Review 10. MicroRNA-34a: a potential therapeutic target in human cancer.